Investment
Features
FeesSafety
Academy
More
Pluang+
|
Home/News Feed/Medtronic faces slow growth and high debt, Hold rating advised with 20% price drop for better value
MDT
$80.57
+$0.10 +0.12%

Medtronic faces slow growth and high debt, Hold rating advised with 20% price drop for better value

Analyst Insights
23 Apr 2026
Seeking Alpha
View Source
Neutral
pluang ai news

Medtronic plc, a leading medical device company, is experiencing slow revenue growth and faces challenges from high debt and competitive pressures. Current growth is driven by Cardiac Ablation Solutions and the Stealth AXIS robotic system, while other products like HUGO struggle against competition. Despite a 3.4% dividend yield and stable margins, issues like high overhead costs and rising inventories limit shareholder value. The analyst maintains a Hold rating, suggesting the stock would be more attractive after a 20% price decline.

More News (MDT)

Global blood glucose monitoring market to nearly double to $39.4B by 2035 with 8.9% CAGR driven by AI and home care trends

Global blood glucose monitoring market to nearly double to $39.4B by 2035 with 8.9% CAGR driven by AI and home care trends

The global blood glucose monitoring system market, valued at $16.8 billion in 2025, is projected to grow to $39.4 billion by 2035 at an 8.9% CAGR. Growth is fueled by rising diabetes prevalence, advancements in AI-enabled monitoring devices, and incr...

Market News
Bullish
2 days ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App